Hyperpolarized 13C-pyruvate magnetic resonance imaging in cancer diagnostics

Expert Opinion on Medical Diagnostics

Volumn 6, Issue 4, 2012, Pages 335-345

  Viale, Alessandra ^a   Reineri, Francesca ^a   Dastrù, Walter ^a   Aime, Silvio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

1 13C pyruvate; Cancer; Dynamic nuclear polarization; Hyperpolarization; Metabolic imaging

Indexed keywords

BIOLOGICAL MARKER; CARBON 13; DOXORUBICIN; DOXYCYCLINE; ETOPOSIDE; HYPERPOLARIZED PYRUVATE C 13; LACTIC ACID; PYRUVIC ACID; UNCLASSIFIED DRUG;

BRAIN TUMOR; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER DIAGNOSIS; CARBON NUCLEAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; GLYCOLYSIS; HUMAN; HYPERPOLARIZATION; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; LYMPHOMA; NONHUMAN; PROSTATE ADENOCARCINOMA; REVIEW; TREATMENT RESPONSE; TUMOR CELL; TUMOR LOCALIZATION;

EID: 84863101194     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2012.687372     Document Type: Review

References (68)

1. Ross BD. The biochemistry of living tissues: examination by MRS. NMR Biomed 1992;5:215-19
2. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303-24
3. Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003;49:223-32
4. Simonetti AW, Melssen WJ, van der Graaf M, et al. A chemometric approach for brain tumor classification using magnetic resonance imaging and spectroscopy. Anal Chem 2003;75:5352-61
5. Overhauser AW. Polarization of nuclei in metals. Phys Rev 1953;92:411-15
6. Golman K, in 't Zandt R, Lerche M,et al. Metabolic imaging by hyperpolarized 13C Magnetic Resonance Imaging for in vivo tumor diagnosis. Cancer Res 2006;66:10855-60
7. Brindle KM. Biomedical applications of hyperpolarized 13C magnetic resonance imaging. Prog Nucl Magn Reson Spectrosc 2009;55:285-95
8. Kurhanewicz J, Vigneron DB, Brindle K, et al. Analysis of cancer metabolism by Imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia 2011;13:81-97
9. Kettunen MI, Hu D-E, Witney TH, et al. Magnetization transfer measurements of exchange between hyperpolarized [1-13C]pyruvate and [1-13C]lactate in a murine lymphoma. Magn Reson Med 2010;63:872-80
10. Brindle KM, Bohndiek SE, Gallagher FA, Kettunen MI. Tumor imaging using hyperpolarized 13C magnetic resonance spectroscopy. Magn Reson Med 2011;66:505-19
11. Larson PEZ, Bok R, Kerr AB, et al. Investigation of tumor hyperpolarized [1-13C]-Pyruvate dynamics using time-resolved multiband RF excitation Echo-Planar MRSI. Magn Reson Med 2010;63:582-91
12. Lau AZ, Chen AP, Hurd RE, Cunningham CH. Spectral-spatial excitation for rapid imaging of DNP compounds. NMR Biomed 2011;24:988-96
13. Smith MR, Peterson ET, Gordon JW, et al. In Vivo imaging and spectroscopy of dynamic metabolism using simultaneous (13)C and (1)H MRI. IEEE Trans Biomed Eng 2011;59:45-9
14. Chen AP, Hurd RE, Cunningham CH. Spin tagging for hyperpolarized 13C metabolic studies. J Magn Reson 2012;214:319-23
15. Altes TA, Salerno M. Hyperpolarized gas MR Imaging of the lung. J Thorac Imaging 2004;19:250-8
16. Oros AM, Shah NJ. Hyperpolarized xenon in NMR and MRI. Phys Med Biol 2004;49:R105-53
17. Matsuoka S, Patz S, Albert MS, et al. Hyperpolarized gas MR Imaging of the lung: current status as a research tool. J Thorac Imaging 2009;24:181-8
18. Schroder L, Lowery TJ, Hilty C, et al. Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor. Science 2006;314:446-9
19. Natterer J, Bargon J. Parahydrogen induced polarization. Prog Nucl Magn Reson Spectrosc 1997;31:293-315
20. Duckett SB, Sleigh CJ. Applications of the parahydrogen phenomenon: a chemical perspective. Prog Nucl Magn Reson Spectrosc 1999;34:71-92
21. Viale A, Aime S. Current concepts on hyperpolarized molecules in MRI. Curr Opin Chem Biol 2010;14:90-6
22. Jensen PR, Karlsson M, Meier S, et al. Hyperpolarized amino acids for in vivo assays of transaminase activity. Chem Eur J 2009;15:10010-12
23. Jensen PR, Peitersen T, Karlsson M, et al. Tissue-specific short chain fatty acid metabolism and slow metabolic recovery after ischemia from hyperpolarized NMR in vivo. J Biol Chem 2009;284:36077-82
24. Karlsson M, Jensen PR, in't Zandt R, et al. Imaging of branched chain amino acid metabolism in tumors with hyperpolarized 13C ketoisocaproate. Int J Cancer 2010;127:729-36
25. Wilson DM, Keshari KR, Larson PEZ, et al. Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo. J Magn Reson 2010;205:141-7
26. Hu S, Zhu M, Yoshihara HAI, et al. In vivo measurement of normal rat intracellular pyruvate and lactate levels after injection of hyperpolarized [1-13C] alanine. Magn Reson Imaging 2011;29:1035-40
27. Kohler SJ, Yen Y, Wolber J, et al. In vivo 13Carbon metabolic imaging at 3T with hyperpolarized 13C-1-Pyruvate. Magn Reson Med 2007;58:65-9
28. Golman K, in 't Zandt R, Thaning M. Real-time metabolic imaging. Proc Natl Am Soc 2006;103:11270-5
29. Gallagher FA, Kettunen MI, Hua D-E, et al. Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2] fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Am Soc 2009;106:19801-6
30. Gallagher FA, Kettunen MI, Day SE, et al. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate. Nature 2008;453:940-4
31. Abragam A, Goldman M. Principles of dynamic nuclear polarisation. Rep Prog Phys 1978;41:395-467
32. Comment A, van den Brandt B, Uffmann K, et al. Design and performance of a DNP prepolarizer coupled to a rodent MRI scanner. Conc Magn Reson B 2007;31B:255-69
33. Golman K, Petersson JS, Magnusson P, et al. Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI. Magn Reson Med 2008;59:1005-13
34. Schroeder MA, Cochlin LE, Heather LC, et al. In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc Natl Am Soc 2008;105:12051-6
35. Merritt ME, Harrison C, Storey C, et al. Inhibition of carbohydrate oxidation during the first minute of reperfusion after brief ischemia: NMR detection of hyperpolarized 13CO2 and H13CO3-. Magn Reson Med 2008;60:1029-36
36. Bhattacharya P, Ross BD, Bunger R. Cardiovascular applications of yperpolarized contrast media and metabolic tracers. Exp Biol Med 2009;234:1395-416
37. Schroeder MA, Atherton HJ, Ball DR, et al. Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy. FASEB J 2009;23:2529-38
38. Schroeder MA, Atherton HJ, Cochlin LE, et al. The effect of hyperpolarized tracer concentration on myocardial uptake and metabolism. Magn Reson Med 2009;61:1007-14
39. Lau AZ, Chen AP, Ghugre NR, et al. Rapid multislice imaging of hyperpolarized 13C Pyruvate and bicarbonate in the heart. Magn Reson Med 2010;64:1323-31
40. Malloya CR, Merritt ME, Sherry AD. Could 13C MRI assist clinical decisionmaking for patients with heart disease? NMR Biomed 2011;24:973-9
41. Spielman DM, Mayer D, Yen Y-F, et al. In vivo measurement of ethanol metabolism in the rat liver using magnetic resonance spectroscopy of hyperpolarized [1-13C]pyruvate.Magn Reson Med 2009;62:307-13
42. Hu S, Chen AP, Zierhut ML, et al. In vivo Carbon-13 dynamic MRS and MRSI of normal and fasted rat liver with hyperpolarized 13C-pyruvate. Mol Imaging Biol 2009;11:399-407
43. Merritt ME, Harrison C, Sherry AD, et al. Flux through hepatic pyruvate carboxylase and phosphoenolpyruvate carboxykinase detected by hyperpolarized 13C magnetic resonance. Proc Natl Am Soc 2011;47:19084-9
44. Hu S, Lustig M, Balakrishnan A, et al. 3D compressed sensing for highly accelerated Hyperpolarized 13C MRSI with in vivo applications to transgenic mouse models of cancer. Magn Reson Med 2010;63:312-21
45. Yen Y-F, Le Roux P, Mayer D, et al. T2 relaxation times of 13C metabolites in a rat hepatocellular carcinoma model measured in vivo using 13C-MRS of hyperpolarized [1-13C]pyruvate. NMR Biomed 2010;23:414-23
46. Darpolora MM, Yen Y-F, Chu M.-S, et al. In vivo MRSI of hyperpolarized [1-13C]pyruvate metabolism in rat hepatocellular carcinoma. NMR Biomed 2011;24:506-13
47. Hu S, Balakrishnan A, Bok RA, et al. 13C-Pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. Cell Metabolism 2011;14:131-42
48. Chen AP, Albers MJ, Cunningham CH, et al. Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T - initial experience. Magn Reson Med 2007;58:1099-106
49. Albers MJ, Bok R, Chen AP, et al. Hyperpolarized 13C lactate, pyruvate, and alanine: non-invasive biomarkers for prostate cancer detection and grading. Cancer Res 2008;68:8607-15
50. Lupo JM, Chen AP, Zierhuta ML, et al. Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer. Magn Reson Imaging 2010;28:153-62
51. Nelson SJ, Vigneron D, Kurhanewicz J, et al. DNP-Hyperpolarized 13C magnetic resonance metabolic imaging for cancer applications. Appl Magn Reson 2008;34:533-44
52. Park I, Larson PEZ, Zierhut ML, et al. Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro-Oncol 2010;12:133-44
53. Harris T, Eliyahu G, Frydman L, Degani H. Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells. Proc Natl Am Soc 2009;106:18131-6
54. Day SE, Kettunen MI, Gallagher FA, et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med 2007;13:1382-7
55. Witney TH, Kettunen MI, Day SE, et al. A comparison between radiolabeled Fluorodeoxyglucose uptake and hyperpolarized 13C-labelled pyruvate utilization as methods for detecting tumor response to treatment. Neoplasia 2009;11:574-82
56. Bohndiek SE, Kettunen MI, Hu D, et al. Detection of tumor response to vascular disrupting agent by hyperpolarized 13C magnetic resonance spectroscopy. Mol Cancer Ther 2010;9:3278-88
57. Ward CS, Venkatesh HS, Chaumeil MM, et al. Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. Cancer Res 2010;70:1296-305
58. Chaumeil MM, Ozawa T, Park I, et al. Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma. Neuroimage 2012;59:193-201
59. Dafni H, Larson PEZ, Hu S, et al. Hyperpolarized 13C Spectroscopic Imaging informs on hypoxia-inducible Factor-1 and Myc activity downstream of platelet-derived growth factor receptor. Cancer Res 2010;70:7400-10
60. Seth P, Grant A, Tang J, et al. On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate. Neoplasia 2011;13:60-71
61. Chen AP, Bok R, Zhang W, et al. Serial hyperpolarized 13C 3D-MRSI following therapy in a mouse model of prostate cancer. Proc Int Soc Magn Reson Med 2008;16:888
62. Day SE, Kettunen MI, Cherukuri MK, et al. Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1-13C]Pyruvate and 13C magnetic resonance spectroscopic Imaging. Magn Reson Med 2011;65:557-63
63. Park I, Bok R, Ozawa T, et al. Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging. J Magn Reson Imaging 2011;33:1284-90
64. Board M, Humm S, Newsholme EA. Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. Biochem J 1990;265:503-9
65. Dastidar SG, Sharma SK. Activities of glycolytic enzymes in rapidly proliferating and differentiated C6 glioma cells. Exp Cell Biol 1989;57:159-64
66. Available from: http://clinicaltrials.gov/ show/NCT01229618
67. Witney TH, Kettunen MI, Hu D-E, et al. Detecting treatment response in model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [14-13C2]fumarate. Br J Cancer 2010;103:1400-6
68. Gabellieri C, Reynolds S, Lavie A, et al. Therapeutic target metabolism observed using hyperpolarized 15N Choline. J Am Chem Soc 2008;130:4598-9